News Releases

Bodisen Biotech, Inc. Will Announce Record 3rd Quarter Earnings in the Morning of November 3, 2005 Before Market Opens
Wednesday November 2, 8:30 am ET

NEW YORK--(BUSINESS WIRE)--Nov. 2, 2005--Bodisen Biotech, Inc., listed on the American Stock Exchange (Amex: BBC; website: /) announced today that the company will announce record 3rd quarter financial results in the morning of November 3, 2005 before market opens.

Bodisen Biotech is the first China based environmentally friendly bio fertilizer company listed on a US stock exchange. In 2005, Bodisen was ranked one of the top 100 growth companies by Forbes China. In the 2nd quarter of 2005, Bodisen generated basic earnings per share of $0.18.

About Bodisen Biotech, Inc.

A Delaware company, Bodisen is headquartered in Shaanxi, China's agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields.

With over 60 products and approximately 600 nationwide distribution centers and growing, Bodisen has experienced rapid growth in the recent years. Bodisen's products are based on proprietary agricultural technology jointly developed by company scientists and university laboratories. These products address grains, vegetables, fruit crops and have been proven to increase crop yields by 10% to 35% while 100% environmentally friendly.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.



Bodisen Biotech, Inc.
Investor Relations, 212-566-3503


Source: Bodisen Biotech, Inc.


Copyright © 2004